HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CLOUDBREAK-B

1.190

0.000

Volume:- -

Turnover:- -

Market Cap:1.10B

PE:-11.55

High:1.190

Open:1.190

Low:1.190

Close:1.190

52wk High:9.580

52wk Low:0.900

Shares:925.00M

HK Float Shares:925.00M

Volume Ratio:0.37

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.103

ROE:--

ROA:-190.68%

PB:3.34

PE(LYR):-11.55

PS:521.78

Loading ...

Overview Company News Filings

Exclusive-Hong Kong Regulator Focusing on the Misuse of Proceeds and Fabricated Demand for Share Sales, Sources Say

THOMSON REUTERS

Hong Kong Watchdog Tells Firms How to Cooperate in Raids as Scrutiny of Share Sales Grows

Exclusive-Meeting of Regulator and Broker Execs a Signal of Greater Scrutiny as Hong Kong Goes Through Huge Share Sale Boom, Sources Say

THOMSON REUTERS

Exclusive-Hong Kong Securities Regulator Gave Guidance to Investment Banks on How to Cooperate During Raids, Sources Say

THOMSON REUTERS

Regulatory Intervention Halts Trading of Eye-Care Drug Developer Following Suspected IPO Irregularities

Hong Kong SFC Suspends Cloudbreak Pharma Trading Over Suspected IPO Rigging

MT Newswires Live

CLOUDBREAK-B Trading Halted Starting September 10 Morning

CLOUDBREAK-B: Wealth Strategy Holding Limited Acquires, Long Position Rises to 10.57%

CLOUDBREAK-B: Hung Ka Kung Acquires Shares, Long Position Rises to 10.57%

Cloudbreak Pharma Hy Loss Us$47.9 Mln

THOMSON REUTERS

Cloudbreak Pharma FY26 H1 Net Loss Widens 1,024.6% to US$ 47.95 Million

Cloudbreak Pharma Inc. - Did not Recommend the Payment of an Interim Dividend

THOMSON REUTERS

Cloudbreak Pharma Schedules 31 Aug 2026 Board Meeting to Review H1 2026 Results and Interim Dividend

Bulletin Express

Cloudbreak Pharma Sets Board Meeting to Review Interim Results, Consider Dividend

Cloudbreak Pharma Files HKEX Next-day Disclosure Return, Share Capital Rises by 41.7 Million Shares

We're Keeping An Eye On Cloudbreak Pharma's (HKG:2592) Cash Burn Rate

Simply Wall St.

Cloudbreak Pharma Appoints New Company Secretary and Authorised Representative

Bulletin Express

Cloudbreak Pharma: FDA Clears IND Safety Review for Dry-Eye Candidate CBT-358

Bulletin Express

CLOUDBREAK-B Receives FDA Clearance for Safety Review of CBT-358 Investigational New Drug Application

Cloudbreak Pharma - FDA Completes Safety Review of Cbt-358 Ind Application with no Objection

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/02592/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02592","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02592\",,,,,undefined,":{"symbol":"02592","market":"HK","secType":"STK","nameCN":"CLOUDBREAK-B","latestPrice":1.19,"timestamp":1789089613343,"preClose":1.19,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":925000000,"shares":925000000,"eps":-0.103023,"marketStatus":"Halted","change":0,"latestTime":"09-11 09:20:13","open":1.19,"high":1.19,"low":1.19,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.024,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"listingDate":1751472000000,"exchange":"SEHK","adjPreClose":1.19,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"volumeRatio":0.369999998816,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02592\",,,,,undefined,":{"symbol":"02592","floatShares":925000000,"roa":"-190.68%","roe":"--","lyrEps":-0.103023,"volumeRatio":0.369999998816,"shares":925000000,"dividePrice":0,"high":1.19,"amplitude":0,"preClose":1.19,"low":1.19,"week52Low":0.9,"pbRate":"3.34","psRate":"521.78","week52High":9.58,"institutionHeld":0,"latestPrice":1.19,"eps":-0.103023,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.024,"open":1.19,"prevYearClose":5.2,"prevWeekClose":1.19,"prevMonthClose":1.145,"prevQuarterClose":1.56,"fiveDayClose":1.18,"twentyDayClose":1.175,"sixtyDayClose":1.21},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02592\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"02592","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null},{"date":"2026-03-30","symbol":"02592","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-29","symbol":"02592","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02592\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02592\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02592\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02592","date":"2026-09-11","current":-1.162109,"percent":0.97619,"low":-24.505522,"twenty":-11.839754,"median":-5.586446,"eighty":-2.054785,"high":-1.021022,"avg":-6.532259,"sd":4.944909,"marketCap":1005033411},"quantilePoints":[{"date":"2025-07-04","current":-6.317277,"twenty":-6.610502,"median":-6.500542,"eighty":-6.390583,"marketCap":4915912241},{"date":"2025-07-11","current":-6.166376,"twenty":-6.470405,"median":-6.317277,"eighty":-6.263403,"marketCap":4798467239},{"date":"2025-07-18","current":-6.350904,"twenty":-6.498689,"median":-6.350281,"eighty":-6.263403,"marketCap":4941079027},{"date":"2025-07-25","current":-6.080141,"twenty":-6.48004,"median":-6.306537,"eighty":-6.134066,"marketCap":4731355809},{"date":"2025-08-01","current":-5.497985,"twenty":-6.418895,"median":-6.177156,"eighty":-6.011186,"marketCap":4278353657},{"date":"2025-08-08","current":-5.49809,"twenty":-6.350655,"median":-6.13405,"eighty":-5.65539,"marketCap":4278353657},{"date":"2025-08-15","current":-5.725306,"twenty":-6.343182,"median":-6.058573,"eighty":-5.554248,"marketCap":4446132232},{"date":"2025-08-22","current":-5.53457,"twenty":-6.315129,"median":-6.004685,"eighty":-5.554248,"marketCap":4286742586},{"date":"2025-08-29","current":-5.503941,"twenty":-6.295753,"median":-5.870846,"eighty":-5.538055,"marketCap":4253186871},{"date":"2025-09-05","current":-5.413205,"twenty":-6.239682,"median":-5.742284,"eighty":-5.49926,"marketCap":4186075441},{"date":"2025-09-12","current":-12.640894,"twenty":-6.350655,"median":-5.870846,"eighty":-5.508123,"marketCap":4118964011},{"date":"2025-09-19","current":-12.711577,"twenty":-6.612702,"median":-6.004685,"eighty":-5.525012,"marketCap":4135741868},{"date":"2025-09-26","current":-11.804503,"twenty":-12.358821,"median":-6.058573,"eighty":-5.527436,"marketCap":3842129362},{"date":"2025-10-03","current":-6.439136,"twenty":-12.191113,"median":-6.134046,"eighty":-5.53457,"marketCap":2096453591},{"date":"2025-10-10","current":-5.988337,"twenty":-11.881825,"median":-6.134089,"eighty":-5.548508,"marketCap":1949083838},{"date":"2025-10-17","current":-12.3346,"twenty":-12.21981,"median":-6.187936,"eighty":-5.561014,"marketCap":4009907937},{"date":"2025-10-24","current":-11.844495,"twenty":-12.25273,"median":-6.279578,"eighty":-5.580054,"marketCap":3850518291},{"date":"2025-10-31","current":-12.15705,"twenty":-12.335851,"median":-6.333467,"eighty":-5.585568,"marketCap":3951185436},{"date":"2025-11-07","current":-11.838569,"twenty":-12.273198,"median":-6.424535,"eighty":-5.601607,"marketCap":3850518291},{"date":"2025-11-14","current":-11.510378,"twenty":-12.207573,"median":-6.465107,"eighty":-5.621104,"marketCap":3741462218},{"date":"2025-11-21","current":-12.23865,"twenty":-12.234818,"median":-6.500592,"eighty":-5.630174,"marketCap":3984741151},{"date":"2025-11-28","current":-21.343443,"twenty":-12.412307,"median":-6.613869,"eighty":-5.677994,"marketCap":6946032996},{"date":"2025-12-05","current":-20.614529,"twenty":-12.626633,"median":-6.790202,"eighty":-5.718633,"marketCap":6711142992},{"date":"2025-12-12","current":-17.961539,"twenty":-12.716498,"median":-11.142834,"eighty":-5.735493,"marketCap":5847083331},{"date":"2025-12-19","current":-14.819321,"twenty":-12.837409,"median":-11.27102,"eighty":-5.75741,"marketCap":4823634025},{"date":"2025-12-24","current":-14.055026,"twenty":-12.984934,"median":-11.600706,"eighty":-5.767869,"marketCap":4571966163},{"date":"2026-01-02","current":-11.620216,"twenty":-12.995771,"median":-11.729724,"eighty":-5.769371,"marketCap":3783406861},{"date":"2026-01-09","current":-7.540769,"twenty":-12.961935,"median":-11.510378,"eighty":-5.972321,"marketCap":2457956120},{"date":"2026-01-16","current":-8.049692,"twenty":-12.941587,"median":-11.169175,"eighty":-5.988337,"marketCap":2625734695},{"date":"2026-01-23","current":-6.609576,"twenty":-12.863288,"median":-10.620058,"eighty":-5.996682,"marketCap":2155954686},{"date":"2026-01-30","current":-6.294491,"twenty":-12.820156,"median":-9.452561,"eighty":-6.004685,"marketCap":2055287541},{"date":"2026-02-06","current":-5.800172,"twenty":-12.797534,"median":-8.075865,"eighty":-6.004685,"marketCap":1895897895},{"date":"2026-02-13","current":-5.772062,"twenty":-12.788929,"median":-7.957902,"eighty":-5.976779,"marketCap":1887508966},{"date":"2026-02-20","current":-5.722622,"twenty":-12.762909,"median":-7.89408,"eighty":-5.899654,"marketCap":1870731109},{"date":"2026-02-27","current":-5.716309,"twenty":-12.718958,"median":-7.540769,"eighty":-5.819712,"marketCap":1870731109},{"date":"2026-03-06","current":-5.592845,"twenty":-12.7039,"median":-6.802294,"eighty":-5.77076,"marketCap":1828786465},{"date":"2026-03-13","current":-5.252211,"twenty":-12.674344,"median":-6.763399,"eighty":-5.752368,"marketCap":1719730391},{"date":"2026-03-20","current":-4.787506,"twenty":-12.644727,"median":-6.625153,"eighty":-5.711698,"marketCap":1568729674},{"date":"2026-03-27","current":-4.279308,"twenty":-12.631386,"median":-6.530805,"eighty":-5.600393,"marketCap":1400951099},{"date":"2026-04-02","current":-4.3756,"twenty":-12.611231,"median":-6.512878,"eighty":-5.567465,"marketCap":1434506814},{"date":"2026-04-10","current":-4.248889,"twenty":-12.593551,"median":-6.499576,"eighty":-5.532786,"marketCap":1392562170},{"date":"2026-04-17","current":-3.434267,"twenty":-12.529717,"median":-6.439136,"eighty":-5.502771,"marketCap":1124116451},{"date":"2026-04-24","current":-3.028108,"twenty":-12.499065,"median":-6.412742,"eighty":-5.465751,"marketCap":1604675194},{"date":"2026-04-30","current":-2.35827,"twenty":-12.455796,"median":-6.350281,"eighty":-5.436669,"marketCap":1249957520},{"date":"2026-05-08","current":-2.422963,"twenty":-12.412307,"median":-6.306537,"eighty":-5.348441,"marketCap":1283740155},{"date":"2026-05-15","current":-2.215232,"twenty":-12.362936,"median":-6.237324,"eighty":-5.224545,"marketCap":1173946589},{"date":"2026-05-22","current":-2.103037,"twenty":-12.335851,"median":-6.187936,"eighty":-5.079251,"marketCap":1114826977},{"date":"2026-05-29","current":-2.055189,"twenty":-12.29622,"median":-6.159956,"eighty":-4.693687,"marketCap":1089490000},{"date":"2026-06-05","current":-1.943602,"twenty":-12.236095,"median":-6.134636,"eighty":-4.452767,"marketCap":1030370388},{"date":"2026-06-12","current":-2.070618,"twenty":-12.215803,"median":-6.134042,"eighty":-4.302022,"marketCap":1097935659},{"date":"2026-06-18","current":-1.863414,"twenty":-12.1843,"median":-6.080141,"eighty":-4.208883,"marketCap":988142093},{"date":"2026-06-26","current":-1.607919,"twenty":-12.150518,"median":-6.004708,"eighty":-3.379693,"marketCap":853011550},{"date":"2026-07-03","current":-2.053171,"twenty":-12.124388,"median":-5.992509,"eighty":-2.739542,"marketCap":1089490000},{"date":"2026-07-10","current":-2.134398,"twenty":-12.109822,"median":-5.972321,"eighty":-2.532616,"marketCap":1131718295},{"date":"2026-07-17","current":-2.101828,"twenty":-11.973906,"median":-5.886479,"eighty":-2.422963,"marketCap":1114826977},{"date":"2026-07-24","current":-2.069578,"twenty":-11.968515,"median":-5.84391,"eighty":-2.309668,"marketCap":1097935659},{"date":"2026-07-31","current":-1.862057,"twenty":-11.947093,"median":-5.798666,"eighty":-2.247923,"marketCap":988142093},{"date":"2026-08-07","current":-1.925288,"twenty":-11.910048,"median":-5.770977,"eighty":-2.212119,"marketCap":1021924729},{"date":"2026-08-14","current":-1.869116,"twenty":-11.882099,"median":-5.767494,"eighty":-2.165101,"marketCap":992364923},{"date":"2026-08-21","current":-1.909914,"twenty":-11.871403,"median":-5.723964,"eighty":-2.134253,"marketCap":1013479070},{"date":"2026-08-28","current":-1.839188,"twenty":-11.868929,"median":-5.708624,"eighty":-2.114609,"marketCap":975473605},{"date":"2026-09-04","current":-1.052314,"twenty":-11.849329,"median":-5.61954,"eighty":-2.086117,"marketCap":996587752},{"date":"2026-09-11","current":-1.061097,"twenty":-11.839754,"median":-5.586446,"eighty":-2.054785,"marketCap":1005033411}],"updateTime":1789335838505},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02592\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666547320","title":"Exclusive-Hong Kong Regulator Focusing on the Misuse of Proceeds and Fabricated Demand for Share Sales, Sources Say","url":"https://stock-news.laohu8.com/highlight/detail?id=2666547320","media":"THOMSON REUTERS","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666547320?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:39","pubTimestamp":1789115991,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL8N4520JP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1956131251.USD","BK0015","LU0516422952.EUR","LU0405327148.USD","LU1820825898.SGD","BK0188","LU0516423174.USD","02592","LU0823397285.USD","LU1328615791.USD","LU2289578879.USD","LU1997244956.HKD","LU0823413660.USD","LU0516422440.USD","LU0823397103.USD","BK0196","LU0516422366.SGD","LU1997245177.USD","SG9999006597.SGD","BK0187","LU1146622755.USD","BK0201","LU2580892789.USD","601211","BK0183","SG9999001226.SGD","LU2495084118.USD","LU1580142542.USD","LU2148510915.USD","600030","LU1064131003.USD","BK0012","LU1997245094.SGD","601066","BK0028","BK0278","LU1655091616.SGD","SG9999001051.SGD","LU1781817850.SGD","BK0175","LU0405327494.USD","LU1969619763.USD","LU1255011170.USD","601939","LU2213484517.USD","LU0516423091.SGD","LU0823413587.USD","LU2328871848.SGD","SGXZ90724238.SGD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666473005","title":"Hong Kong Watchdog Tells Firms How to Cooperate in Raids as Scrutiny of Share Sales Grows","url":"https://stock-news.laohu8.com/highlight/detail?id=2666473005","media":"Reuters","labels":["shareholding","policyRegulatory","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666473005?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:39","pubTimestamp":1789115991,"startTime":"0","endTime":"0","summary":"EXCLUSIVE-Hong Kong watchdog tells firms how to cooperate in raids as scrutiny of share sales growsHONG KONG, Sept 11 (Reuters)-Hong Kong's securities watchdog gave guidance to investment banks on how","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL8N4520JP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,policyRegulatory,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064130708.USD","LU1969619763.USD","LU0039217434.USD","600030","601211","BK0196","LU1328615791.USD","BK1161","LU1146622755.USD","LU1655091616.SGD","BK0187","BK0015","BK0028","LU1997245177.USD","LU1255011170.USD","SG9999001051.SGD","LU1781817850.SGD","601939","LU0823397285.USD","LU0516422366.SGD","BK0276","LU2213484517.USD","LU0516422952.EUR","LU1820825898.SGD","LU1997244956.HKD","LU2148510915.USD","SG9999006597.SGD","BK0012","SG9999001226.SGD","LU0405327494.USD","LU1956131251.USD","LU0516423091.SGD","LU0516422440.USD","LU1997245094.SGD","BK0278","LU0516423174.USD","LU2580892862.HKD","SGXZ90724238.SGD","BK0183","LU2580892789.USD","BK0201","BK0184","02592","LU2328871848.SGD","BK0175","LU0823397103.USD","SG9999001093.SGD","LU0823413587.USD","LU0823413660.USD","601066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666322547","title":"Exclusive-Meeting of Regulator and Broker Execs a Signal of Greater Scrutiny as Hong Kong Goes Through Huge Share Sale Boom, Sources Say","url":"https://stock-news.laohu8.com/highlight/detail?id=2666322547","media":"THOMSON REUTERS","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666322547?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:39","pubTimestamp":1789115990,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL8N4520JP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1969619763.USD","LU0039217434.USD","600030","601211","BK0196","LU1328615791.USD","LU1655091616.SGD","LU2495084118.USD","BK0187","BK0015","BK0028","LU1997245177.USD","LU2289578879.USD","LU1255011170.USD","SG9999001051.SGD","LU1781817850.SGD","601939","LU0823397285.USD","LU0516422366.SGD","BK0188","BK0276","LU2213484517.USD","LU0516422952.EUR","LU1820825898.SGD","LU1997244956.HKD","SG9999006597.SGD","LU1064131003.USD","BK0012","SG9999001226.SGD","LU0405327494.USD","LU1956131251.USD","LU0516423091.SGD","LU0516422440.USD","BK0278","LU0516423174.USD","LU2580892862.HKD","SGXZ90724238.SGD","BK0183","LU2580892789.USD","BK0201","BK0184","LU1580142542.USD","02592","LU2328871848.SGD","BK0175","LU0823397103.USD","SG9999001093.SGD","LU0823413587.USD","LU0823413660.USD","601066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666754732","title":"Exclusive-Hong Kong Securities Regulator Gave Guidance to Investment Banks on How to Cooperate During Raids, Sources Say","url":"https://stock-news.laohu8.com/highlight/detail?id=2666754732","media":"THOMSON REUTERS","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666754732?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:39","pubTimestamp":1789115989,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL8N4520JP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999001051.SGD","SG9999006597.SGD","LU2495084118.USD","LU0823397285.USD","BK0012","601211","LU0405327494.USD","BK0175","BK0187","LU0823397103.USD","LU2580892789.USD","LU1969619763.USD","SG9999001093.SGD","BK0276","LU0516422952.EUR","LU0516423174.USD","LU1064131003.USD","LU0516423091.SGD","LU0405327148.USD","LU0823413587.USD","BK0028","02592","BK0201","BK0196","LU1064130708.USD","600030","LU2580892862.HKD","SG9999001226.SGD","LU2328871848.SGD","BK1161","BK0278","LU1781817850.SGD","601066","LU1255011170.USD","601939","LU0516422366.SGD","LU0039217434.USD","LU1997245094.SGD","LU1580142542.USD","LU1146622755.USD","BK0184","LU2289578879.USD","BK0183","LU1997245177.USD","SGXZ90724238.SGD","LU1328615791.USD","LU0516422440.USD","LU1997244956.HKD","LU1956131251.USD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140079980","title":"Regulatory Intervention Halts Trading of Eye-Care Drug Developer Following Suspected IPO Irregularities","url":"https://stock-news.laohu8.com/highlight/detail?id=1140079980","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140079980?lang=en_us&edition=fundamental","pubTime":"2026-09-11 10:00","pubTimestamp":1789092059,"startTime":"0","endTime":"0","summary":"Hong Kong's securities regulator has ordered the suspension of trading in shares of Cloudbreak Pharma (02592.HK), citing serious concerns that the company's initial public offering may have been...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","MEDX","LNGR","BK4127","06978","BK1574","KCE","159992","FRHC","REDS","IBBQ","02592","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666121205","title":"Hong Kong SFC Suspends Cloudbreak Pharma Trading Over Suspected IPO Rigging","url":"https://stock-news.laohu8.com/highlight/detail?id=2666121205","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666121205?lang=en_us&edition=fundamental","pubTime":"2026-09-11 09:16","pubTimestamp":1789089409,"startTime":"0","endTime":"0","summary":"Hong Kong's Securities and Futures Commission suspended trading in Cloudbreak Pharma (HKG:2592) shares on Thursday, according to a statement.The regulator said it had serious concerns that the company's initial public offering may have been rigged to create an artificial impression of demand.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02592","BK1161","IPOS","FRHC","BK4127","KCE","REDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190178142","title":"CLOUDBREAK-B Trading Halted Starting September 10 Morning","url":"https://stock-news.laohu8.com/highlight/detail?id=1190178142","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190178142?lang=en_us&edition=fundamental","pubTime":"2026-09-10 09:10","pubTimestamp":1789002619,"startTime":"0","endTime":"0","summary":"CLOUDBREAK-B (02592) has officially announced a suspension of its share trading activities.As detailed in the company's latest filing, the trading halt has been mandated by the Securities and Futures...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112566503","title":"CLOUDBREAK-B: Wealth Strategy Holding Limited Acquires, Long Position Rises to 10.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=1112566503","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112566503?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:43","pubTimestamp":1788860635,"startTime":"0","endTime":"0","summary":"Wealth Strategy Holding Limited bought 70.52 million shares of CLOUDBREAK-B (02592) at an average of HKD 1.0 per share on September 3, 2026, involving about HKD 70.52 million.Prior to the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108313898","title":"CLOUDBREAK-B: Hung Ka Kung Acquires Shares, Long Position Rises to 10.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=1108313898","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108313898?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:15","pubTimestamp":1788858944,"startTime":"0","endTime":"0","summary":"Hung Ka Kung bought 70.52 million shares of CLOUDBREAK-B stock at an average of HKD 1.0000 per share on September 3, 2026, involving about HKD 70.52 million.Prior to the acquisition, Hung Ka Kung's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663740460","title":"Cloudbreak Pharma Hy Loss Us$47.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663740460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663740460?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:38","pubTimestamp":1788172716,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nPLX70K4KN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02592","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663707409","title":"Cloudbreak Pharma FY26 H1 Net Loss Widens 1,024.6% to US$ 47.95 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663707409","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663707409?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:37","pubTimestamp":1788172673,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma FY26 H1 net loss widens 1,024.6% to US$ 47.95 millionCloudbreak Pharma posted a net loss of US$47.95 million, swinging from profit, as operating loss widened 43.56% to US$48.34 milli","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL8VV5g0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663740640","title":"Cloudbreak Pharma Inc. - Did not Recommend the Payment of an Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2663740640","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663740640?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:37","pubTimestamp":1788172656,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S063:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02592","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130257316","title":"Cloudbreak Pharma Schedules 31 Aug 2026 Board Meeting to Review H1 2026 Results and Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1130257316","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130257316?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:28","pubTimestamp":1787149739,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma Inc. has announced that its board of directors will convene on 31 August 2026 to review and approve the Group’s unaudited interim results for the six months ended 30 June 2026. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660429842","title":"Cloudbreak Pharma Sets Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2660429842","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660429842?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:13","pubTimestamp":1787148804,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma sets board meeting to review interim results, consider dividendCloudbreak Pharma will hold a board meeting on Aug. 31, 2026 to review unaudited interim results for the six months end","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL3jHvLn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656179053","title":"Cloudbreak Pharma Files HKEX Next-day Disclosure Return, Share Capital Rises by 41.7 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2656179053","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656179053?lang=en_us&edition=fundamental","pubTime":"2026-08-02 18:28","pubTimestamp":1785666534,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma files HKEX next-day disclosure return, share capital rises by 41.7 million sharesCloudbreak Pharma filed a next-day disclosure return covering share issuances on July 31 under incent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260802:nNDL62VlWB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656314281","title":"We're Keeping An Eye On Cloudbreak Pharma's (HKG:2592) Cash Burn Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2656314281","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656314281?lang=en_us&edition=fundamental","pubTime":"2026-08-02 09:09","pubTimestamp":1785632981,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2592/cloudbreak-pharma-shares/news/were-keeping-an-eye-on-cloudbreak-pharmas-hkg2592-cash-burn","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2592/cloudbreak-pharma-shares/news/were-keeping-an-eye-on-cloudbreak-pharmas-hkg2592-cash-burn","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133013404","title":"Cloudbreak Pharma Appoints New Company Secretary and Authorised Representative","url":"https://stock-news.laohu8.com/highlight/detail?id=1133013404","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133013404?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:44","pubTimestamp":1784285044,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma Inc. announced that, effective 17 July 2026, Ms. Fung Nga Fong has resigned from her roles as Company Secretary and Authorised Representative under both the Hong Kong Listing Rules...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140542229","title":"Cloudbreak Pharma: FDA Clears IND Safety Review for Dry-Eye Candidate CBT-358","url":"https://stock-news.laohu8.com/highlight/detail?id=1140542229","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140542229?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:43","pubTimestamp":1784285039,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma Inc. (CLOUDBREAK-B) reported that the U.S. Food and Drug Administration completed its safety review of the investigational new drug (IND) application for CBT-358 on 14 July 2026...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155527014","title":"CLOUDBREAK-B Receives FDA Clearance for Safety Review of CBT-358 Investigational New Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1155527014","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155527014?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:42","pubTimestamp":1784284941,"startTime":"0","endTime":"0","summary":"CLOUDBREAK-B (ASX: 02592) has announced the completion of the review period concerning the Investigational New Drug (IND) application for CBT-358, which was submitted to the U.S. Food and Drug...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK1161","BK4090","02592","BMED","CBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652402226","title":"Cloudbreak Pharma - FDA Completes Safety Review of Cbt-358 Ind Application with no Objection","url":"https://stock-news.laohu8.com/highlight/detail?id=2652402226","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652402226?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:39","pubTimestamp":1784284756,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nFWN43J0EN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02592"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":70,"code":"91000000","status":"200"}]}}